Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.3.175

Development of Poly(D,L-lactic acid) Microspheres Containing Lorazepam  

Choi, Han-Gon (College of Pharmacy Yeungnam University)
Yoo, Bong-Kyu (College of Pharmacy Yeungnam University)
Rhee, Jong-Dal (College of Pharmacy Yeungnam University)
Kim, Jung-Ae (College of Pharmacy Yeungnam University)
Kwon, Tae-Hyub (College of Pharmacy Yeungnam University)
Woo, Jong-Soo (College of Pharmacy Yeungnam University)
Yong, Chul-Soon (College of Pharmacy Yeungnam University)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.3, 2006 , pp. 175-184 More about this Journal
Abstract
Poly(D,L-lacic acid)(PLA) microshperes containing loazepam were prepared by a solvent-emulsion evaporation method and their release patterns were investigated in vitro. Various batches of microspheres with different size and drug content were obtained by changing the ratio of lorazepam to PLA, PLA concentration in the dispersed phase and stirring rate. Rod-like lorazepam crystals on microsphere surface, which were released rapidly and could act as a loading dose, were observed with increasing drug content. The release rate was increased with increase in drug contents and decrease in the molecular weight of PLA. The release rate of lorazepam for long-acting injectable delivery system in vitro, which would aid in Predicting in vivo release Profile, could be controlled by properly optimizing various factors affecting characteristics of microspheres.
Keywords
Lorazepam; Poly(D,L-lactic acid); Microspheres; Injectable delivery system;
Citations & Related Records
연도 인용수 순위
  • Reference
1 R.J. Linhardt, Biodegradable polymers for controlled release of drugs: In Controlled Release of Drugs: Polymers and Aggregate Systems, M. Rosoff (Ed.), VCH Publishers, New York, U.S.A, pp. 53-96, (1988)
2 J.R. Robinson (Ed.), Sustained and Controlled Release Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1978
3 B. Conti, F. Pavanetto and I. Genta, Use of polylactic acid for the preperation of microparticulate drug delivery system, J. Microencapsulation, 9, 153-166 (1992)   DOI
4 M. Chasin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1990
5 T. Kawaguchi, A Tsugane, K. Higashide, H. Endoh, H. Kanno, T. Seki, K. Juni, S. Fukushima and M. Nakino, Control of drug release with a combination of prodrug and polymer matrix, J. Pharm. Sci., 81, 508-512 (1992)   DOI
6 C.G Pitt, M.M. Gratzl, A.R. Jeffcoat, R. Zweidinger and A. Schindler, Sustained drug delivery systems, J. Pharm. Sci. 68, 1534-1538 (1979)   DOI
7 L.R. Beck, D.R. Cowsar, D.H. Lewis, R.J. Cosgrove, C.T. Riddle, S.L. Lowry and T. Epperly, A new long-acting injectable microcapsule system for the administration of progesterone, Fertility and Sterility, 31, 545-551 (1979)   DOI
8 A. Schindler, R. Jeffcoat, G.L. Kimmel, C.G. Pitt, M.E. Wall and R. Zweidinger (Eds.), Contemporary Topics in Polymer Science, Plenum Press, New York, U.S.A, pp. 251-286 (1977)
9 D.L. Wise, T.D. Fellmann, J.E. Sanderson and R.L. Wentworth (Eds.), Lactic-Glycolic Acid Polymers in Drug Carriers in Biology and Medicine, Academic Press, Orlando, Fla., pp. 237-270 (1979)
10 H. Endoh, T. Kawaguchi, T. Seki, T. Hasegawa and K. Juni, Controlled release of 5-Fluoro-2-deoxyuridine by the combination of prodrug and polymer matrix, Chem. Pharm. Bull., 39, 458-464 (1991)   DOI   ScienceOn
11 L.R. Beck, C.E. Flowers, V.Z. Pope, W.H. Wilborn and T.R. Tice, Clinical evaluation of improved injectable microcapule contraceptive system, Am. J. Obstet. Gynecol., 147, 815-821 (1983)   DOI
12 G. Spenlehauer, M. Veillard and J.P. Benoit, Formation and characterization of cisplatin loaded poly(d,1-lactide) microspheres for chemoembolization, J. Pharm. Sci., 75, 750-755 (1986)   DOI
13 J.H.P. Woodland and S. Yolles, Long-acting delivery systems for narcotic antagonists, J. Med. Chem., 16, 897-901 (1973)   DOI
14 N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics, Chem. Pharm. Bull., 29, 3363-3368 (1981)   DOI   ScienceOn
15 N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing dibucaine, Chem. Pharm. Bull., 30, 3719-3727 (1982)   DOI   ScienceOn
16 A.K. Kwong, S. Chou, A.M. Sun, M.V. Sefton and M.F.A. Goosen, In vitro and in vivo release of insulin from polyl (actic acid) microbeads and pellets, J. Controlled Release, 4, 47-62 (1986)   DOI   ScienceOn
17 S.M. Li, H. Garreau and M. Vert, Structure-property relationships in the case of the degradation of massive aliphatic poly-($\alpha$-hydroxy acids) ill aqueous media, part 1: poly(DL-lactic acid), J. Materi. Sci.; Materials in medicine, 1, 123-130 (1990)   DOI
18 Y. Ogawa, H. Okada, M. Yamamoto and Y. Shimamoto, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic!glycolic) acids in vitro degradation ofthese polymers, Chem. Pharm. Bull., 36, 2576-2581 (1988)   DOI   ScienceOn
19 Y. Ogawa, H. Okada, T. Heya and Y. Shimamoto, Controlled release of LHRH agonists, leuprolide acetate, from micro- capsules: Serum drug level profiles and pharmacological effects in animals, J. Pharm. Pharmacol., 41, 439-444 (1989)   DOI
20 I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, Preparation ofneurotensin analogue-containing poly(DL-lactic acid) microsperes formed by oil-in water solvent evaporation, J. Pharm. Sci., 81, 899-903 (1992)   DOI
21 K. Makino, M. Arakawa and T. Kondo, Preparation and in vitro degradation properties of polylactide microcapsules, Chem. Pharm. Bull., 33, 1195-1201 (1985)   DOI   ScienceOn
22 Y.W. Chien (Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A., pp. 465-545 (1982)
23 S.N. Muchohi, K Obiero, G.O. Kokwaro, B.R. Ogutu, I.M. Githiga, G. Edwards and C.R.J.C. Newton, Determination of lorazepam in plasma from children by high-performance liquid chromatography with UV detection, Journal of Chromatography B, 824, 333-340 (2005)   DOI   ScienceOn
24 X.-P. Lee, T. Kumazawa, J. Sato, Y. Shoji, C. Hasegawa, C. Karibe, T. Arinobu, H. Seno and K Sato, Simple method for the determination ofbenzodiazepines in human body fluids by high-performance liquid chromatography-mass spectrometry, Analytica Chimica Acta, 492, 223-231 (2003)   DOI   ScienceOn
25 H. Zhu and J. Luo, A fast and sensitive liquid chromatographic- tandem mass spectrometric method for assay of lorazepam and application to pharmacokinetic analysis, J. Pharmaceutical and Biomedical Analysis, 39, 268-274 (2005)   DOI   ScienceOn
26 D.L. Thies and P.B. Bowman, Development of liquid chromatographic method for the determination of triazolo-benzodiazepines, J. Chromato., 268, 92-98 (1983)   DOI   ScienceOn
27 J. Heller, Biodegradable polymers in controlled drug delivery, CRC Crit. Rev. Ther. Drug. Carrier Systems, 1, 39-90 (1984)
28 G.L. Klerman, Overview of the cross-national collaborative panic study, Arch. Gen. Psychiatry, 45, 407-412 (1988)   DOI   ScienceOn
29 J. Claassen, L.J. Hirsch and S.A. Mayer, Treatment of status epilepticus: A survey ofneurologists, J. Neurological Sci., 211, 37-41 (2003)   DOI
30 J.-Y. Chung, J.-Y. Cho, K.-S. Yu, J.-R. Kim, H.-R. Jung, K-S. Lim, I.-J. Jang and S.-G Shin, Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers, Clinical Pharmacology & Therapeutics, 77, 486-494 (2005)   DOI   ScienceOn
31 F.G. Hutchinson and B.J.A. Furr, Biodegradable polymer systems for the sustained release of polypeptides, J. Controlled Release, 13, 279-294 (1990)   DOI   ScienceOn
32 J. Dreyfus, J.J. Ross and B.C. Schreiber, Excretion and biotransformation of the enanthate ester of $fluphenazine-^{14}C$ by the dog, J. Pharm. Sci., 60, 829-833 (1971)   DOI
33 P. Johnson and J.G. Lloyed-Jones (Eds.), Drug Delivery Systems: Fundamentals and Techniques, Ellis Horwood, England Chichester, 1987
34 K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori and M. Akagi, Preparation and evaluation in vitro of polylactic acid micropsheres containing doxorubicin, Chem. Pharm. Bull., 33, 313-318 (1985)   DOI   ScienceOn
35 I.J. Oh, J.Y. Oh and K.C. Lee, Assessment of biodegrada- bility of polymeric microspheres in vivo: poly(DL-lactic acid), poly(L-lactic acid) and poly(DL-lactide-co-glycolide) microspheres, Arch. Pharm. Res., 16, 312-317 (1993)   DOI
36 I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, In vitro and in vivo release of poly(DL-lactic acid) micro- spheres containing neurotensin analogue prepared by novel oil-in water solvent evaporation method, J. Pharm. Sci., 81, 808-811 (1992)   DOI
37 Y.W. Chien (Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A,1992
38 C. Sturesson, J. Carlfors, K Edsman and M. Andersson, Preparation of biodegradable poly(lactic-co-glycolic)acid microspheres and their in vitro release of timolol maleate, Int. J. Pharm., 89, 235-244 (1993)   DOI   ScienceOn
39 K. Suzuki and J.C. Price, Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly (d,l-lactide), J. Pharm. Sci., 74, 21-24 (1985)   DOI
40 B.J.A. Furr and F.G. Hutchinson, A biodegradable delivery system for peptides: Preclinical experience with the gona- dotrophin- releasing hormone agonist $Zoladex^{R}$', J. Controlled Release, 21, 117-128 (1992)   DOI   ScienceOn